FXYD5/Dysadherin Antibody [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28555F
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Functional
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Recombinant Monoclonal Human IgG1 expressed in CHO
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Dysadherin
Clonality
Monoclonal
Host
Human
Isotype
IgG1
Description
The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
Patent #: US20140079722
Patent #: US20140079722
Applications for FXYD5/Dysadherin Antibody [FITC]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: FXYD5/Dysadherin
Long Name
FXYD Domain-containing Ion Transport Regulator 5
Alternate Names
DYSAD, Dysadherin, EF-8, IWU1, KCT1, OIT2, PRO6241, RIC
Gene Symbol
FXYD5
Additional FXYD5/Dysadherin Products
Product Documents for FXYD5/Dysadherin Antibody [FITC]
Product Specific Notices for FXYD5/Dysadherin Antibody [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...